Profile
ACOR ZTS TAK HLN TEVA ITCI
Company Name Acorda Therapeutics, Inc. Zoetis Inc. Takeda Pharmaceutical Company Limited Haleon plc Teva Pharmaceutical Industries Limited Intra-Cellular Therapies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $821.03K $73.16B $47.84B $46.83B $19.50B $14.05B
Employees 0.10K 13.80K 49.28K 24.56K 37.00K 0.86K
CEO Dr. Ron Cohen M.D. Ms. Kristin C. Peck Mr. Christophe Weber Mr. Brian James McNamara Richard D. Francis Dr. Sharon Mates Ph.D.
Ratings
Trading
ACOR ZTS TAK HLN TEVA ITCI
Last Close $0.661 $157.23 $14.97 $10.5 $17 $131.87
High 52 $0.66 $196.48 $15.39 $11.41 $22.77 $131.91
Low 52 $0.66 $144.45 $12.89 $8.26 $12.82 $67.99
Price vs. 52 Week High 0.15 % -19.98 % -2.73 % -7.98 % -25.34 % -0.03 %
Price vs. 52 Week Low 0.15 % 8.85 % 16.14 % 27.12 % 32.61 % 93.95 %
Total Return
ACOR ZTS TAK HLN TEVA ITCI
1 Month Return 0 % -3.29 % 2.75 % -5.75 % 0.24 % 0 %
3 Month Return 0 % -3.43 % -0.33 % 4.48 % 8.35 % 0.14 %
6 Month Return 0 % -5.01 % 13.93 % 7.8 % -24.85 % 53.34 %
9 Month Return 0 % -19.32 % 2.18 % -0.85 % -4.17 % 80.13 %
YTD Return 0 % -3.5 % 13.07 % 10.06 % -22.87 % 57.89 %
1 Year Return 0 % -8 % 15.87 % 23.53 % 4.62 % 85.5 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ACOR ZTS TAK HLN TEVA ITCI
Dividend Yield Percentage (TTM) - 1.13 % 4.52 % 0.01 % - -
Dividend Paid and Capex Coverage Ration (TTM) -527.34 % 2 % 1.65 % - 2.53 % -227.26 %
Dividend Per Share (TTM) - 1.86 % 196 % 0.05 % - -
Payout Ratio (TTM) - 32.25 % 280.28 % - - -
Growth
ACOR ZTS TAK HLN TEVA ITCI
Asset Growth -70.24 % 0.76 % -9.55 % 87.69 %
Gross Profit Growth -18.87 % -0.19 % 5.47 % 44.88 %
Revenue Growth -0.79 % -0.61 % 4.4 % 46.62 %
Revenue 3 Year -74.97 % 19.01 % 1.52 % 556.51 %
Revenue 5 Year -92.13 % 33.95 % -5.5 % 600974.32 %
Revenue 10 Year -90.22 % 33.95 % -38.45 % 32663.23 %
EBIT Growth -3382.25 % 13.52 % -169.63 % 26.77 %
Net Income Growth -283.6 % 37.46 % -193.2 % 46.54 %
Net Income 3 Yeari Growth Per Share 17.38 % 4.91 % -482.97 % 79.29 %
Net Income 5 Yeari Growth Per Share -336.79 % 122.63 % -58.26 % 72.95 %
Net Income 10 Yeari Growth Per Share -530.12 % 122.63 % -140.46 % 32.41 %
Operating Income Growth 44.66 % 10.52 % -169.98 % 26.77 %
Operating Cash Flow Growth (CFG) 33.17 % 9.57 % -8.85 % 41.08 %
Operating 3 Year CFG 92.54 % 71.6 % 52.26 % 77.79 %
Operating 5 Year CFG -102.93 % 196.04 % 123.59 % 69.4 %
Operating 10 Year CFG -109.96 % 196.04 % -81.66 % 10.87 %
EPS Growth -204.32 % 45.45 % -190 % 50.68 %
EPS Diluted Growth -204.32 % 45.45 % -190 % 50.68 %
Book Value Per Share -233.85 % -1.63 % -30.36 % 80.54 %
Share Holder 3 Year Equity Growth Per Share -121.6 % -37.97 % -49 % 116.52 %
Share Holder 5 Year Equity Growth Per Share -108.14 % -40.16 % -62.86 % 215.14 %
Share Holder 10 Year Equity Growth Per Share -110.03 % -40.16 % -82.6 % 164.65 %
Dividend Per Share Growth - 49.01 % - -
Dividend 3 Year Growth Per Share - -49.79 % - -
Dividend 5 Year Growth Per Share -100 % -49.97 % -100 % -
Dividend 10 Year Growth Per Share - -49.97 % -100 % -
Debt Growth 10.4 % 6.83 % -10.29 % 0.25 %
Free Cash Flow Growth 32.35 % 16.27 % -11.05 % 40.95 %
Updated On 31 Dec 2023 31 Dec 2024 31 Dec 2024 31 Dec 2024
Profitability
ACOR ZTS TAK HLN TEVA ITCI
Gross Profit Margin TTM 70.83 % 70.2 % 54.7 % 61.52 % 49.17 % 91.63 %
Return on Assets TTM -300.53 % 17.86 % 0.76 % 4.2 % -3.35 % -5.46 %
Return on Equity TTM 142.65 % 51.32 % 1.48 % 8.73 % -21.38 % -7.4 %
Return on Capital Employed TTM 12.75 % 32.08 % 3.75 % 7.74 % 1.59 % -10.05 %
Net Income Per EBT TTM 86.58 % 78.79 % 61.12 % 75.5 % 246.36 % 100.64 %
EBT Per Ebit TTM 1560.32 % 92.99 % 40.08 % 86.58 % -120.28 % 63.57 %
EBIT Per Revenue TTM -31.14 % 37.01 % 9.62 % 19.64 % 2.61 % -17.15 %
Cash Flow To Debt Ratio TTM -11.84 % 43.63 % 21.32 % - 7.47 % -430.93 %
Receivables Turnover TTM 6.34 6.82 6.32 5.9 4.91 4.09
Payables Turnover TTM 1.71 6.51 4.36 2.19 3.69 2.18
Inventory Turnover TTM 1.2 1.16 1.7 3.63 2.6 2.17
Fixed Asset Turnover TTM 998.87 % 253.65 % 232.78 % 584.75 % 332.7 % 4569.25 %
Asset Turnover TTM 71.44 % 65.87 % 32.15 % 32.73 % 43.25 % 49.79 %
Operating Cash Flow Per Share TTM -18.68 6.58 608.55 - 1.11 -0.71
Free Cash Flow Per Share TTM -18.72 5.1 443.26 - 0.67 -0.71
Cash Per Share TTM 753.95 % 384.5 % 24349.44 % 24.05 % 149.12 % 970.67 %
Operating Cash Flow Sales Ratio TTM -39.82 % 31.71 % 21.01 % - 7.62 % -10.75 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.19 % 77.45 % 72.84 % - 60.43 % 100.44 %
Cash Flow Coverage Ratios TTM -11.84 % 43.63 % 21.32 % - 7.47 % -430.93 %
Price To Free Cash Flows Ratio TTM -0.04 32.07 9.73 - 25.68 -191.12
Price To Operating Cash Flows Ratio TTM -0.04 24.98 7.13 - 15.4 -185.85
Price Cash Flow Ratio TTM -0.04 24.98 7.13 - 15.4 -185.85
Income Statement (TTM)
ACOR ZTS TAK HLN TEVA ITCI
Revenue $0.12B $9.26B $4263.76B $11.23B $16.54B $0.68B
Gross Profit $0.07B $6.54B $2832.26B $6.95B $8.06B $0.62B
Gross Profit Ratio 60.86% 70.62% 66.43% 61.85% 48.74% 91.63%
EBITDA $0.01B $3.87B $874.6B $2.51B $0.72B $-0.12B
Net Income $-0.25B $2.49B $144.07B $1.44B $-1.64B $-0.07B
EPS Diluted -203.59 5.47 45.58 0.32 -1.45 -0.72
Balance Sheet (MRQ)
ACOR ZTS TAK HLN TEVA ITCI
Long Term Debt $0B $5.39B $5029.93B $8.54B $16.3B $0.01B
Total Liabilities $0.28B $9.47B $7834.79B $18.09B $33.61B $0.22B
Total Equity $-0.16B $4.77B $7274.01B $16.22B $5.72B $1.15B
Total Investments $0B $0B $445.7B $0.08B $0B $0.69B
Total Debt $0.19B $6.74B $4843.75B $10.1B $18.08B $0.02B
Total Assets $0.12B $14.24B $15108.79B $34.32B $39.33B $1.37B
Cash Flow Statement (TTM)
ACOR ZTS TAK HLN TEVA ITCI
Net Income $-0.25B $2.5B $144.07B $1.44B $-1.96B $-0.07B
Inventory $-0B $-0.04B $-115.74B $0.22B $0.17B $-0.01B
Dividends Paid $0B $-0.79B $-287.19B $-0.57B $0B $0B
Operating Cash Flow $-0.01B $2.95B $716.34B $2.3B $1.25B $-0.07B
Capital Expenditure $-0B $-0.66B $-480.73B $-0.25B $-0.5B $-0B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 4.255
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 1.43
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 9.42
ALVOW Alvotech 1.7
AMPH Amphastar Pharmaceuticals, Inc. 23.16
AMRX Amneal Pharmaceuticals, Inc. 8.12
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 65.72
APUS Apimeds Pharmaceuticals US, Inc 1.7183
AQST Aquestive Therapeutics, Inc. 3.255
ASRT Assertio Holdings, Inc. 0.6501
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 9.28
AYTU Aytu BioPharma, Inc. 2.07
ETFs With Exposure to ACOR
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 302.04
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00001 133.77
VXF Vanguard Extended Market Index Fund 0 191.48
VSTCX Vanguard Strategic Small-Cap Equity Fund Investor Shares 0 38.51
IEIH iShares Evolved U.S. Innovative Healthcare ETF 0 34.1348
VTSAX Vanguard Total Stock Market Index Fund 0 145.69
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 143.65
VITSX Vanguard Total Stock Market Index Fund 0 145.72
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 143.66
VEMPX Vanguard Extended Market Index InstlPlus 0 354.51
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 273.35
Unlock